Match!

Maximizing the return on taxpayers' investments in fundamental biomedical research.

Published on May 1, 2015in Molecular Biology of the Cell3.905
· DOI :10.1091/mbc.E14-06-1163
Jon R. Lorsch43
Estimated H-index: 43
(NIH: National Institutes of Health)
Abstract
The National Institute of General Medical Sciences (NIGMS) at the U.S. National Institutes of Health has an annual budget of more than $2.3 billion. The institute uses these funds to support fundamental biomedical research and training at universities, medical schools, and other institutions across the country. My job as director of NIGMS is to work to maximize the scientific returns on the taxpayers' investments. I describe how we are optimizing our investment strategies and funding mechanisms, and how, in the process, we hope to create a more efficient and sustainable biomedical research enterprise.
  • References (17)
  • Citations (18)
📖 Papers frequently viewed together
383 Citations
6 Authors (J M Doyle, ..., M S Lauer)
21 Citations
198536.22Cell
26 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
References17
Newest
#1Narasimhan S. Danthi (NIH: National Institutes of Health)H-Index: 7
#2Colin O. Wu (NIH: National Institutes of Health)H-Index: 50
Last. Michael S. Lauer (NIH: National Institutes of Health)H-Index: 86
view all 5 authors...
Rationale: The American Recovery and Reinvestment Act (ARRA) allowed National Heart, Lung, and Blood Institute to fund R01 grants that fared less well on peer review than those funded by meeting a payline threshold. It is not clear whether the sudden availability of additional funding enabled research of similar or lesser citation impact than already funded work. Objective: To compare the citation impact of ARRA-funded de novo National Heart, Lung, and Blood Institute R01 grants with concurrent ...
12 CitationsSource
A number of distressing trends, including a decline in the share of key research grants going to younger scientists, as well as a steady rise in the age at which investigators receive their first funding, are now a decades-long feature of the US biomedical research workforce. Working committees have proposed recommendations, policy makers have implemented reforms, and yet the trajectory of our funding regime away from young scientists has only worsened. An investigation of some of the major fact...
84 CitationsSource
Most scientists (ourselves included) headed off to graduate school eager to discover new things, test crazy ideas, and hopefully change the world, or at least explain a piece of it. Sadly, these days such aspirations are overshadowed by fierce competition for papers, grants, and the tenured
9 CitationsSource
#1Jonathan R. KaltmanH-Index: 26
#2Frank EvansH-Index: 14
Last. Michael S. LauerH-Index: 86
view all 6 authors...
Rationale:We previously demonstrated absence of association between peer-review–derived percentile ranking and raw citation impact in a large cohort of National Heart, Lung, and Blood Institute cardiovascular R01 grants, but we did not consider pregrant investigator publication productivity. We also did not normalize citation counts for scientific field, type of article, and year of publication. Objective:To determine whether measures of investigator prior productivity predict a grant’s subseque...
40 CitationsSource
#1Stephen A. GalloH-Index: 20
#2Afton S. CarpenterH-Index: 3
Last. Scott R. GlissonH-Index: 6
view all 8 authors...
There is a paucity of data in the literature concerning the validation of the grant application peer review process, which is used to help direct billions of dollars in research funds. Ultimately, this validation will hinge upon empirical data relating the output of funded projects to the predictions implicit in the overall scientific merit scores from the peer review of submitted applications. In an effort to address this need, the American Institute of Biological Sciences (AIBS) conducted a re...
24 CitationsSource
#1Bruce M. Albertsll (UCSF: University of California, San Francisco)H-Index: 72
#2Marc W. Kirschner (Harvard University)H-Index: 149
Last. Harold E. VarmusH-Index: 120
view all 4 authors...
383 CitationsSource
Late June, 1969, at a suburban Philadelphia day camp. There was much to look forward to: color war, soccer, nature hikes, bug juice, barbecues, swimming, softball, and, of course, no school! But I paid little attention, as for me these paled compared with the upcoming big event, the much-anticipated launch of Apollo 11, the rocket that would fulfill President Kennedy’s call to land men on the moon and bring them back home. During the next few weeks, my parents and I spent hours glued to the TV; ...
8 CitationsSource
#1Wil A. M. Loenen (LUMC: Leiden University Medical Center)H-Index: 5
#2David T. F. Dryden (LUMC: Leiden University Medical Center)H-Index: 36
Last. Noreen E. Murray (LUMC: Leiden University Medical Center)H-Index: 43
view all 5 authors...
In the early 1950’s, ‘host-controlled variation in bacterial viruses’ was reported as a non-hereditary phenomenon: one cycle of viral growth on certain bacterial hosts affected the ability of progeny virus to grow on other hosts by either restricting or enlarging their host range. Unlike mutation, this change was reversible, and one cycle of growth in the previous host returned the virus to its original form. These simple observations heralded the discovery of the endonuclease and methyltransfer...
114 CitationsSource
#1Jeremy M Berg (University of Pittsburgh)H-Index: 53
The development of robust science policy depends on use of the best available data, rigorous analysis, and inclusion of a wide range of input. While director of the National Institute of General Medical Sciences (NIGMS), I took advantage of available data and emerging tools to analyze training time distribution by new NIGMS grantees, the distribution of the number of publications as a function of total annual National Institutes of Health support per investigator, and the predictive value of pee...
2 CitationsSource
#1Henry R. Bourne (UCSF: University of California, San Francisco)H-Index: 84
The relentless expansion that threatens the sustainability of biomedical research in the US takes a heavy toll on young researchers.
27 CitationsSource
Cited By18
Newest
#1Anne K. Krueger (Humboldt University of Berlin)H-Index: 1
#2Barbara Hendriks (Humboldt University of Berlin)H-Index: 1
Last. Stephan Gauch (Humboldt University of Berlin)H-Index: 1
view all 3 authors...
Translational research is a buzzword which dominates discussions about the quality, the utilization, and the benefits of (bio)medical research. Yet, although translational research has become a prominent topic, no commonly agreed definition of this terminology exists. Instead, experts from different contexts such as biomedical research, clinical practice or nursing discuss translational research in multiple ways depending on how they define the problem that translational research is supposed to ...
Source
#1Rory M. Power (Morgridge Institute for Research)H-Index: 3
#1Rory M. Power (Morgridge Institute for Research)H-Index: 1
Last. Jan Huisken (Morgridge Institute for Research)H-Index: 36
view all 2 authors...
The growth of advanced, custom microscopy has outpaced commercialization, with biologists unable to benefit from these developments. We propose a complementary model for access based on shareable, traveling and configurable microscopes, with potential benefits for biologists, developers and the community.
6 CitationsSource
#1Falk Leichsenring (University of Giessen)H-Index: 40
#1Falk Leichsenring (University of Giessen)H-Index: 21
Last. John P. A. Ioannidis (Stanford University)H-Index: 157
view all 3 authors...
1 CitationsSource
#1Kaare Aagaard (AU: Aarhus University)H-Index: 7
#2Alexander Kladakis (AU: Aarhus University)H-Index: 1
Last. Mathias Wullum Nielsen (AU: Aarhus University)H-Index: 9
view all 3 authors...
The relationship between the distribution of research funding and scientific performance is a major discussion point in many science-policy contexts. Do high shares of funding handed out to a limit...
1 CitationsSource
The NIH is the federal steward of biomedical research in the United States. Taxpayers fund the NIH; the NIH supports research into the underlying biology, etiology, and treatment of diseases; and benefits of that research are returned to taxpayers. This is a large and complex enterprise, but at its core are two fundamental principles. The NIH is obligated to distribute its research grants and grant dollars in a fair and impartial manner among qualified investigators nationwide and to maximize th...
Source
#1Wayne P. Wahls (University of Arkansas for Medical Sciences)H-Index: 20
Scientific output is not a linear function of amounts of federal grant support to individual investigators. As funding per investigator increases beyond a certain point, productivity decreases. This study reports that such diminishing marginal returns also apply for National Institutes of Health (NIH) research project grant funding to institutions. Analyses of data (2006-2015) for a representative cross-section of institutions, whose amounts of funding ranged from 3 million to 40 million per ...
1 CitationsSource
#1Wayne P. Wahls (University of Arkansas for Medical Sciences)H-Index: 20
: New data from the NIH reveal that the scientific return on its sponsored research reaches a maximum at around $400,000 of annual support per principal investigator. We discuss the implications of this 'sweet spot' for funding policy, and propose that the NIH should limit both the minimum and maximum amount of funding per researcher.
7 CitationsSource
#1Bo Wu (PRC: China Medical University (PRC))H-Index: 2
#2Fengrong Ou (PRC: China Medical University (PRC))H-Index: 3
Last. Yang Liu (PRC: China Medical University (PRC))H-Index: 26
view all 13 authors...
A principal investigator is obligated not only to make academic impacts but also to do so in a cost-effective fashion. While popular bibliometric measures such as the journal impact factor (IF) and the H-index measure citation-oriented bibliometric impacts, here we propose the E-index to reflect a principal investigator’s research efficiency also in terms of bibliometric data. Our E-index incorporates both IF-citation-based output and “total equivalent time” that the principal investigator...
Source
#1Linton WinderH-Index: 1
#2Simon HodgeH-Index: 17
1 CitationsSource
#1Mark Peifer (UNC: University of North Carolina at Chapel Hill)H-Index: 65
: The United States has been a leader in biomedical science for decades, in large part because of the strategy used by the National Institutes of Health (NIH) to invest its budgetary portfolio. They identified talented young scientists from each generation and gave them the resources they needed to initiate and maintain strong research programs. However, recently this investment has become less diversified, with a larger fraction of grant dollars in the hands of a smaller fraction of researchers...
6 CitationsSource